Registration is closed. Thank you for your overwhelming support.
Health systems, providers, patients, payers, and regulators around the globe are actively exploring how best to utilise the increasing amounts of real-world data (RWD) and real-world evidence (RWE) that can be actively generated during routine care. This symposium, hosted by the Duke-NUS Centre of Regulatory Excellence and Duke University’s Robert J. Margolis, MD, Center for Health Policy, will convene thought leaders to discuss their efforts to harness RWD and RWE for a range of purposes. A particular focus of the discussion will be on the potential regulatory acceptability of these sources of evidence. An opening presentation from Duke-Margolis will provide a high-level overview of the major challenges in this space, followed by sharing of perspectives from global experts and questions from the audience.
Registration Fee: $50
Due to the limited availability of seats, early registration is strongly recommended.
The Centre of Regulatory Excellence is an accredited provider for Continuing Professional Education (CPE) for Pharmacists and Continuing Medical Education (CME) for Doctors.
Continuing education credits are available for CoRE events through the Singapore Pharmacy Council and the Singapore Medical Council subject to their respective approvals.
Attendees who wish to avail of the credits are required to sign the relevant registration form along with their CPE/CME number on the day of the events.
Should the event be conducted online, please provide your CPE/CME number in the respective e-registration form.
The attendee’s registration details will be submitted after the event and credited upon receiving respective approvals.
Date and Time
23 Sep 2019 @ 15:00 - 23 Sep 2019 @ 17:30
Prof Mark McClellan
Professor of Business, Medicine and Policy
Duke-Margolis Center for Health Policy
A/Prof Kelvin Bryan Tan
Policy, Research and Evaluation Division
Ministry of Health
Adjunct Associate Professor
Centre of Regulatory Excellence
Duke-NUS Medical School
A/Prof James Yip
Group Chief Medical Information Officer
National University Health System
Chief Data Advisor
Ministry of Health
Mr Bart Barefoot
Value Evidence & Outcomes and Real-World Evidence Policy, Advocacy, and External Collaboration
Ms Sally Soh
Vigilance and Compliance Branch
Health Products Regulation Group
Health Sciences Authority